简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook
The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda.
Trump's tariffs could soon bring higher food prices for some Americans, analysis finds
President Donald Trump’s blanket tariffs scheduled for Aug. 1 could bring higher prices on certain foods, economist says. Here’s what to know.
UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers
UnitedHealth’s 2025 earnings guidance fell well short of Wall Street estimates, in the latest setback for the company.
Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal
The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.
While the Fed kept its benchmark unchanged, here's what happened to consumer borrowing rates
Even while the Fed left its benchmark rate unchanged, many consumer rates have fluctuated over the first half of the year.
How Trump Just Turned Europe Into A Vassal Market
On Sunday, the United States and the European Union agreed on a new framework for transatlantic trad
U.S. Treasury yields hold steady ahead of Fed meeting
U.S. Treasury yields were flat on Tuesday, just ahead of the Federal Reserve’s two-day policy meeting.
U.S. 10-year Treasury yield eases as traders brace for Wednesday's Fed decision
U.S. Treasury yields were lower on Tuesday, just ahead of the Federal Reserve’s two-day policy meeting.
Samsung backs South Korean AI chip startup Rebellions ahead of IPO
Rebellions has been working with Samsung to bring its second-generation artificial intelligence chip, called Rebel, to market.
Jeep maker Stellantis reinstates financial guidance but flags tough decisions' ahead
Auto giant Stellantis has touted a gradual recovery over the coming months.
CNBC Daily Open: Investors are signaling it's time for tariffs to move aside
Economists appear to be lowering their expectations of the impact tariffs will have on the U.S. economy.
Barclays second-quarter profit beats estimates as investment banking revenues swell
Investors have been watching the performance of the lender’s sharpened investment banking unit, which posted income of £3.3 billion the three months to…
Philips shares up 8% as health tech giant flags reduced U.S. tariff impact
Join CNBC for the latest news on what’s moving European markets.
Philips shares up 10% as health tech giant flags reduced U.S. tariff impact
Join CNBC for the latest news on what’s moving European markets.
European stocks head for higher open; AstraZeneca beats estimates
Join CNBC for the latest news on what’s moving European markets.
European stocks head for higher open with earnings and U.S. trade deals in focus
Join CNBC for the latest news on what’s moving European markets.
Europe sets its sights on multi-billion-euro gigawatt factories as it plays catch-up on AI
The gigafactories could add 15% to Europe’s total computing capacity, according to estimates from UBS.
Singapore Airlines shares fall more than 8% after first quarter profit plunges
Shares of Singapore Airlines fell after the carrier reported a 59% decline in earnings for the first quarter of its 2025/2026 financial year.
Singapore Airlines shares fall more than 8% after first-quarter profit plunges
Shares of Singapore Airlines fell after the carrier reported a 59% decline in earnings for the first quarter of its 2025/2026 financial year.
Even with high tariffs, Trump's trade war suddenly is starting to look not so scary on Wall Street
Economists cite several factors as reasons for why the landscape looks less dire.
